Definitive persistence or disappearance of clinical (A) or ECG/Holter (B) after the first treatment, 2008–2017, in patients with Chagas disease acquired by the oral route, Chacao, Caracas, Venezuela. (DOCX)</p
Artículo de publicación ISIObjectives: To evaluate cases of chronic Chagas’ disease for the long-ter...
The objective of this report is to describe treatment outcomes over a four-year period of patients w...
OBJECTIVE: To identify and associate potential electrocardiographic and echocardiographic changes in...
Definitive persistence or disappearance of clinical (A) or ECG/Holter (B) findings after the first t...
Incidence of clinical (A) and ECG/Holter (B) findings after treatment in 106 patients with Chagas di...
Cumulative incidence of clinical and ECG/Holter findings after treatment in 106 patients with Chagas...
Prevalence of clinical findings and ECG/Holter abnormalities in the follow-up of 106 patients with o...
Prevalence of significant associations between the pre and post-treatment clinical and ECG/Holter fi...
Incidence of ECG/Holter abnormalities in 106 patients with Chagas disease orally acquired, Chacao, C...
Post-treatment ECG/Holter findings with statistical significance according to age of children with o...
Altered echocardiographic findings and cardiothoracic ratio in the follow-up in patients with Chagas...
Using palpitations as an example to calculate incidence after treatment of clinical or electrocardio...
Abstract Background: In the past two decades, a new epidemiological profile of Chagas’ disease (CD)...
Twenty-eight Chagas disease patients (CD), 22 with the indeterminate clinical form (IND) and six wit...
ABSTRACTA woman had been followed since 1957 for acute phase Chagas disease. Parasitological and ser...
Artículo de publicación ISIObjectives: To evaluate cases of chronic Chagas’ disease for the long-ter...
The objective of this report is to describe treatment outcomes over a four-year period of patients w...
OBJECTIVE: To identify and associate potential electrocardiographic and echocardiographic changes in...
Definitive persistence or disappearance of clinical (A) or ECG/Holter (B) findings after the first t...
Incidence of clinical (A) and ECG/Holter (B) findings after treatment in 106 patients with Chagas di...
Cumulative incidence of clinical and ECG/Holter findings after treatment in 106 patients with Chagas...
Prevalence of clinical findings and ECG/Holter abnormalities in the follow-up of 106 patients with o...
Prevalence of significant associations between the pre and post-treatment clinical and ECG/Holter fi...
Incidence of ECG/Holter abnormalities in 106 patients with Chagas disease orally acquired, Chacao, C...
Post-treatment ECG/Holter findings with statistical significance according to age of children with o...
Altered echocardiographic findings and cardiothoracic ratio in the follow-up in patients with Chagas...
Using palpitations as an example to calculate incidence after treatment of clinical or electrocardio...
Abstract Background: In the past two decades, a new epidemiological profile of Chagas’ disease (CD)...
Twenty-eight Chagas disease patients (CD), 22 with the indeterminate clinical form (IND) and six wit...
ABSTRACTA woman had been followed since 1957 for acute phase Chagas disease. Parasitological and ser...
Artículo de publicación ISIObjectives: To evaluate cases of chronic Chagas’ disease for the long-ter...
The objective of this report is to describe treatment outcomes over a four-year period of patients w...
OBJECTIVE: To identify and associate potential electrocardiographic and echocardiographic changes in...